Document Detail


Experimental and clinical study of crystalloid cardioplegic solution in neonatal period and early infancy. Effects of calcium and prostacyclin analogue.
MedLine Citation:
PMID:  3052917     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effects of calcium and a prostacyclin (PGI2) analogue in the glucose-insulin-potassium (GIK) cardioplegic solution for the neonatal period and early infancy were evaluated. The assessment was based mainly on semiquantitative scoring of mitochondrial damage and intracellular edema in postreperfusion biopsies. Experimentally, 45 isolated perfused newborn rabbit hearts (age, 0-2 days) underwent 2 hours of global ischemia at 15 degrees C with a single dose of GIK cardioplegic solution and were subsequently assigned to three groups: Group 1 hearts (n = 15) were infused with basic GIK cardioplegic solution alone (no added calcium, but measured at 0.1-0.2 mM/l); Group 2 hearts (n = 15) received GIK cardioplegic solution with calcium (1.2 mM); and Group 3 hearts (n = 15) received GIK cardioplegic solution with calcium and a PGI2 analogue (OP-41483, 300 micrograms/l). Group 3 hearts showed significantly lower mitochondrial damage and intracellular edema scores than did Group 1 and Group 2 hearts (p less than 0.05). Hemodynamic measurement (aortic flow and coronary flow) results after reperfusion were also better in Group 3 hearts than in the hearts of the other two groups (p less than 0.05). In the clinical study with 18 infants who were less than 3 months old, the same three cardioplegic solutions were used. Group 2 (n = 6) and Group 3 (n = 5) infants showed significantly lower mitochondrial damage scores than did Group 1 (n = 7) infants. Group 3 infants also showed significantly lower intracellular edema scores than did Group 1 and Group 2 infants.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
Y Sawa; H Matsuda; Y Shimazaki; K Kadoba; S Ohtake; H Takami; S Onishi; Y Kawashima
Related Documents :
12838197 - Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants ...
1392417 - Investigations into ro-specific antibody-associated congenital cardiac conduction defects.
3843237 - Endocardial fibrosis and hydrops fetalis in a premature infant.
3923047 - Pulsed doppler fetal echocardiography.
23229697 - The chop postnatal weight gain, birth weight, and gestational age retinopathy of premat...
19959617 - Neonatal salivary analysis reveals global developmental gene expression changes in the ...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Circulation     Volume:  78     ISSN:  0009-7322     ISO Abbreviation:  Circulation     Publication Date:  1988 Nov 
Date Detail:
Created Date:  1988-12-15     Completed Date:  1988-12-15     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  III191-7     Citation Subset:  AIM; IM    
Affiliation:
First Department of Surgery, Osaka University Medical School, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Animals, Newborn / physiology*
Body Water / metabolism
Calcium / therapeutic use*
Cardiomyopathies / complications,  pathology
Clinical Trials as Topic
Creatine Kinase / metabolism
Edema / complications,  pathology
Epoprostenol / analogs & derivatives*
Heart Defects, Congenital / complications,  surgery
Hemodynamics / drug effects
Humans
Infant
Infant, Newborn
Isoenzymes
Mitochondria, Heart / ultrastructure
Myocardium / ultrastructure
Potassium / therapeutic use
Potassium Compounds*
Rabbits
Chemical
Reg. No./Substance:
0/Isoenzymes; 0/Potassium Compounds; 0/potassium cardioplegic solution; 35121-78-9/Epoprostenol; 7440-09-7/Potassium; 7440-70-2/Calcium; EC 2.7.3.2/Creatine Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intracavitary right heart cooling during coronary bypass surgery. A prospective randomized trial.
Next Document:  Reversal of recalcitrant cardiac allograft rejection with methotrexate.